Kidney Research and Clinical Practice

Ferric citrate for iron deficiency anemia in non-dialysis dependent chronic kidney disease: a randomized phase III study: Mei-Yi Wu, Chin-Chan Lee, Chien-Te Lee et al.; Received May 19, 2025 Accepted November 24, 2025 Published online January 21, 2026; [Epub ahead of print]; Full text PubReader ePub PDF Supplementary Material

Frailty-related factors and 1-year renal function change after sodium-glucose cotransporter-2 inhibitors in elderly chronic kidney disease patients: Hye-Mi Noh, Sei Hong Min, Hyung-Seok Lee, Sung Gyun Kim, Jun Goo Kang, Jwa-Kyung Kim; Received April 16, 2025 Accepted September 1, 2025 Published online December 8, 2025; [Epub ahead of print]; Full text PubReader ePub PDF Supplementary Material

Efficacy and cost-effectiveness of darbepoetin alfa once every 4 weeks versus continuous erythropoietin receptor activator once every 4 weeks for anemia correction in patients with chronic kidney disease not on dialysis: Geo Neul Park, Kyung Ho Lee, Ji Eun Moon et al.; Kidney Res Clin Pract. 2024;43(3):369-380. Published online January 23, 2024; DOI: https://doi.org/10.23876/j.krcp.23.074
Web of Science 1 Cited By 2; Full text PubReader ePub PDF Supplementary Material

Pleotropic effects of hypoxia-inducible factor-prolyl hydroxylase domain inhibitors: are they clinically relevant?: Yu-Hsiang Chou, Szu-Yu Pan, Shuei-Liong Lin; Kidney Res Clin Pract. 2023;42(1):27-38. Published online November 21, 2022; DOI: https://doi.org/10.23876/j.krcp.22.118
Web of Science 5 Cited By 6; Full text PubReader ePub PDF

Ferric carboxymaltose versus ferric gluconate in hemodialysis patients: reduction of erythropoietin dose in 4 years of follow-up: Antonio Lacquaniti, Patrizio Pasqualetti, Teresa Casuscelli di Tocco et al.; Kidney Res Clin Pract. 2020;39(3):334-343. Published online September 30, 2020; DOI: https://doi.org/10.23876/j.krcp.20.015
Web of Science 9 Cited By 11; Full text PubReader PDF

Drug treatment patterns and work productivity in chronic kidney disease patients with anemia in China: cross sectional analysis of real-world data: Heleen van Haalen, James Sloand, Rebecca Moon et al.; Kidney Res Clin Pract. 2020;39(3):318-333. Published online September 30, 2020; DOI: https://doi.org/10.23876/j.krcp.20.020
Web of Science 7 Cited By 8; Full text PubReader PDF

Effects of online hemodiafiltration on anemia and nutritional status in chronic hemodialysis patients: Yu Ho Lee, Yoon Soo Shin, So-Young Lee et al.; Kidney Res Clin Pract. 2020;39(1):103-111. Published online March 31, 2020; DOI: https://doi.org/10.23876/j.krcp.19.082
Web of Science 7 Cited By 10; Full text PubReader PDF

Treatment of renal anemia: Erythropoiesis stimulating agents and beyond: Patrick Biggar, Gheun-Ho Kim; Kidney Res Clin Pract. 2017;36(3):209-223. Published online September 30, 2017; DOI: https://doi.org/10.23876/j.krcp.2017.36.3.209
Web of Science 26 Cited By 24; Full text PubReader PDF

Posterior nutcracker phenomenon with Down syndrome: Eun Sil Koh, Min Young Kim, Yoon Sik Chang, Sungjin Chung; Kidney Res Clin Pract. 2015;34(4):245-246. Published online November 12, 2015; DOI: https://doi.org/10.1016/j.krcp.2015.10.001
Web of Science 2 Cited By 3; Full text PubReader PDF

Optimal hemoglobin level for anemia treatment in a cohort of hemodialysis patients: Mi Yeon Jung, Soon Young Hwang, Yu Ah Hong et al.; Kidney Res Clin Pract. 2015;34(1):20-27. Published online January 15, 2015; DOI: https://doi.org/10.1016/j.krcp.2014.11.003
Web of Science 9 Cited By 9; Full text PubReader PDF

A randomized crossover study of single biweekly administration of epoetin-α compared with darbepoetin-α in chronic kidney disease patients not receiving dialysis: Ha-Young Na, Yong-Kyu Lee, Sug-Kyun Shin et al.; Kidney Res Clin Pract. 2014;33(4):210-216. Published online December 5, 2014; DOI: https://doi.org/10.1016/j.krcp.2014.10.001
Web of Science 1 Cited By 2; Full text PubReader PDF

Understanding and exploiting hepcidin as an indicator of anemia due to chronic kidney disease: Derek S. Larson, Daniel W. Coyne; Kidney Res Clin Pract. 2013;32(1):11-15. Published online January 16, 2013; DOI: https://doi.org/10.1016/j.krcp.2013.01.001
Cited By 15; Full text PubReader PDF

The effect of intravenous ascorbic acid in hemodialysis patients with normoferritinemic anemia: Dae Woong Kang, Chi Yong Ahn, Bong Kwan Ryu, Byung Chul Shin, Jong Hoon Chung, Hyun Lee Kim; Kidney Res Clin Pract. 2012;31(1):48-53. Published online January 20, 2012; DOI: https://doi.org/10.1016/j.krcp.2012.01.002
Web of Science 5 Cited By 6; Full text PubReader PDF

Lupus Cystitis and Azathioprine-iIduced Pure Red Cell Aplasia in a Patient with Systemic Lupus Erythematosus: Tai Yeon Koo Hyun Jung Kim Kyung Min Kim Dong Kyu Oh Geum Borae Park and Sang Koo Lee; Korean J Nephrol. 2011;30(1):102-106.; PDF

25,739	The burden of chronic kidney disease in Asia region: a review of the evidence, current challenges, and future directions
8,757	Management of high-flow arteriovenous access
4,435	Safety and efficacy of glucagon-like peptide 1 receptor agonists in solid organ transplant recipients with diabetes mellitus: a systematic review and meta-analysis
6,968	Clinical guidelines for the diagnosis, evaluation, and management of hypertension for Korean children and adolescents: the Korean Working Group of Pediatric Hypertension
7,774	Precision medicine for focal segmental glomerulosclerosis

Cited By 12	Kidney Health Plan 2033 in Korea: bridging the gap between the present and the future
Cited By 11	Status and trends in epidemiologic characteristics of diabetic end-stage renal disease: an analysis of the 2021 Korean Renal Data System
Cited By 11	School urinary screening program in Japan: history, outcomes, perspectives
Cited By 11	Artificial intelligence and machine learning’s role in sepsis-associated acute kidney injury
Cited By 11	The burden of chronic kidney disease in Asia region: a review of the evidence, current challenges, and future directions

Search